Publicaciones en colaboración con investigadores/as de University College London (9)

2023

  1. Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

    New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347

  2. Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network

    The Lancet Oncology, Vol. 24, Núm. 6, pp. e255-e269

2021

  1. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

    The Lancet Oncology, Vol. 22, Núm. 3, pp. e105-e118

2020

  1. Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set

    Blood, Vol. 136, Núm. 26, pp. 3033-3040

2019

  1. Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016

    British Journal of Haematology

  2. Insights on Multiple Myeloma Treatment Strategies

    HemaSphere, Vol. 3, Núm. 1

  3. Understanding mortality in multiple myeloma: Findings of a European retrospective chart review

    European Journal of Haematology, Vol. 103, Núm. 2, pp. 107-115

2016

  1. Multiple myeloma: patient outcomes in real-world practice

    British Journal of Haematology, Vol. 175, Núm. 2, pp. 252-264

  2. Multiple myeloma: practice patterns across Europe

    British Journal of Haematology, Vol. 175, Núm. 1, pp. 66-76